Highlights
NASDAQ: URGN       Urogen Pharma Ltd
Last Price Today's Change   Day's Range   Trading Volume
21.37   +0.90 (4.40%)  20.39 - 21.52  55,000

Overview

 
Avg Volume (4 weeks):106,620
4 Weeks Range:18.36 - 23.44
4 Weeks Price Volatility (%):
59.25%
52 Weeks Range:13.118 - 35.21
52 Weeks Price Volatility (%):
37.35%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. It has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. The company's lead product candidates, MitoGel and VesiGel, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4328  4069  664  210 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNAP 43.17+4.20 
 SCKT 2.55+1.09 
 GE 7.63-0.09 
 INTC 48.20-5.70 
 AAL 12.60-0.55 
 MRIN 3.45+1.33 
 AAPL 115.04-0.71 
 OAS 0.155-0.014 
 F 8.16-0.05 
 NIO 27.16-0.22